Live tape
Top 8, mentions 7d30,017NVDA14,564 mentions▲ +0.04ANT4,160 mentions▲ +0.06GOOGL2,936 mentions▲ +0.04SPY2,248 mentions▲ +0.05QQQ1,804 mentions▲ +0.04SPCX1,748 mentions▲ +0.08AMD1,367 mentions▲ +0.06AAPL1,190 mentions▲ +0.04

Equity · Healthcare

ZYME

NASDAQ

Zymeworks (ZYME)

27.51 USD −0.24% vs prior close Sep 23, 2026
Zymeworks Inc. price graph
22 sessions
32 24 24 Aug 23 Sep

The line runs 28.74 USD on 24 August through 27.51 USD on 23 September, on a scale from 24 to 32. Days the market did not trade hold the previous close, flat.

Market cap
1.9B USD
P/E (TTM)
52.9
Revenue, year to Dec 2025
106.0M USD
EPS, diluted, year to Dec 2025
−1.08 USD
52-week range
15.89 USD – 31.05 USD
Avg volume
41.7K

as of Sep 23, 2026

Have Zymeworks (ZYME) insiders bought or sold shares recently?

In the 90 days to 22 Nov 2026, Zymeworks insiders reported 3 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 22 Dec 2025, show no open-market purchase.

Form 4, 90 days to 22 Nov 2026, newest reported trade 18 Nov 2026

0buys
3sells
$1.78Mnet sold
3other filings
Have Zymeworks (ZYME) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
18 Nov 2026Platshon ScottEVP, Chief Business OfficerSell15,292382K USD
13 Nov 2026Moore Paul AndrewChief Scientific OfficerSell39,7411.0M USD
09 Oct 2026Schayowitz AdamEVP, Head of R&DSell13,832358K USD
Sold3 open-market sales68,865$1.78M
3 other filings in the window: grants, exercises, tax withholding and transfers, not trades
Have Zymeworks (ZYME) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
18 Nov 2026Platshon ScottEVP, Chief Business OfficerOption exercise37,037
13 Nov 2026Moore Paul AndrewChief Scientific OfficerOption exercise25,000146K USD
09 Oct 2026Schayowitz AdamEVP, Head of R&DOption exercise37,037

Which funds hold Zymeworks (ZYME)?

10 of the 45 institutional funds we track reported a Zymeworks position for the quarter ended 30 Sep 2026 — a combined 84.0M USD; the latest of those filings landed 16 Nov 2026.

Form 13F

Which funds hold Zymeworks (ZYME)?
FundPositionSharesValueShares q/q
Citadel AdvisorsAdded1,192,39131.6M USD+30.4%
Fisher Asset ManagementAdded608,61216.1M USD+759.9%
Millennium ManagementNew position400,07410.6M USD
Man GroupAdded342,1919.1M USD+62.3%
D. E. Shaw & Co.Added233,4416.2M USD+61.2%
Two Sigma InvestmentsAdded133,8733.5M USD+86.3%
AQR Capital ManagementHeld (±25%)130,3373.5M USD+17.1%
Point72 Asset ManagementNew position75,3692.0M USD
Marshall WaceTrimmed27,109718K USD−33.8%
Renaissance TechnologiesNew position26,800710K USD

What has been filed or recorded for Zymeworks (ZYME)?

The filings we hold for Zymeworks, newest first: 1 fails-to-deliver day, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 29 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Zymeworks (ZYME)?
And
29 Oct 2026Fails to deliverShares failed to deliver2 shares58 USD notional · <0.001% of shares out
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS 2.28 USDRevenue $256M
30 Sep 2026FinancialsTotal assets1.2B USDat period end
30 Sep 2026FinancialsTotal equity258.3M USDat period end
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS −0.62 USDRevenue $5M
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS −0.59 USDRevenue $2M
31 Dec 2025Annual reportFY 2025 reportedEPS −1.08 USDRevenue $106M
31 Dec 2025FinancialsRevenue106.0M USDfiscal year
31 Dec 2025FinancialsNet income−81.1M USDfiscal year
31 Dec 2025FinancialsDiluted EPS−1.08 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS −0.26 USDRevenue $28M
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS 0.03 USDRevenue $49M
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS −0.30 USDRevenue $27M
31 Dec 2024Annual reportFY 2024 reportedEPS −1.62 USDRevenue $76M

What do people ask about Zymeworks (ZYME)?

From live data
What did Zymeworks shares close at?27.51

Zymeworks closed at 27.51 USD on 23 Sep 2026, down 0.24% on the close before. That is the end-of-day price from Finazon, not a live quote.

What is Zymeworks’ market cap?1.9B

Zymeworks is worth 1.9B USD by market value as of 23 Sep 2026, which is the share price times the shares on issue from its SEC filings.

What is Zymeworks’ P/E ratio?52.9

Zymeworks has a price-to-earnings ratio of 52.9, as of 23 Sep 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.

What is Zymeworks’ revenue?106.0M

Zymeworks reported revenue of 106.0M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Have Zymeworks insiders bought or sold shares recently?3 sales

In the 90 days to 22 Nov 2026, Zymeworks insiders reported 3 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 22 Dec 2025, show no open-market purchase. A further 3 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders

Which funds own Zymeworks?10 of 45

10 of the 45 funds we track reported a Zymeworks position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were Citadel Advisors, Fisher Asset Management and Millennium Management. See Funds

When did Zymeworks last report earnings?2.28

Zymeworks last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 2.28 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  7. SEC EDGARreported earnings figures and scheduled report dates
  8. SEC EDGARValuation computed from SEC EDGAR filings
  9. SEC filingAbout text: the company's latest annual report filed with the SEC (Business section), summarised in our own words